Share This Author
A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer.
Adjuvant chemotherapy has a significant survival benefit in patients with resected pancreatic cancer, whereas adjuvant chemoradiotherapy has a deleterious effect on survival.
The 2016 update of the International Study Group (ISGPS) definition and grading of postoperative pancreatic fistula: 11 Years After
Preoperative/Neoadjuvant Therapy in Pancreatic Cancer: A Systematic Review and Meta-analysis of Response and Resection Percentages
- S. Gillen, T. Schuster, C. Meyer zum Büschenfelde, H. Friess, J. Kleeff
- MedicinePLoS medicine
- 1 April 2010
Jörg Kleef and colleagues systematically reviewed studies on neoadjuvant therapy and tumor response, toxicity, resection, and survival percentages in pancreatic cancer and suggest that patients with…
Primary malignant hepatic epithelioid hemangioendothelioma
A comprehensive review of the literature on HEH is presented, with a focus on clinical outcome after different therapeutic strategies, to suggest LTx is an acceptable option for patients who have HEH with extrahepatic manifestation.
Acute Necrotizing Pancreatitis: Treatment Strategy According to the Status of Infection
- M. Büchler, B. Gloor, C. Müller, H. Friess, C. Seiler, W. Uhl
- MedicineAnnals of surgery
- 1 November 2000
These results support nonsurgical management, including early antibiotic treatment, in patients with sterile pancreatic necrosis, and for them surgical treatment seems preferable.
Adjuvant chemotherapy with fluorouracil plus folinic acid vs gemcitabine following pancreatic cancer resection: a randomized controlled trial.
Compared with the use of fluorouracil plus folinic acid, gemcitabine did not result in improved overall survival in patients with completely resected pancreatic cancer.
Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: a randomised controlled trial
European experts consensus statement on cystic tumours of the pancreas.
Desmoplastic Reaction in Pancreatic Cancer: Role of Pancreatic Stellate Cells
Activated PSCs are present in theStromal reaction in pancreatic cancers and are responsible for the production of stromal collagen.
VEGF expression by mesenchymal stem cells contributes to angiogenesis in pancreatic carcinoma
It is shown that mesenchymal stem cells supported tumour angiogenesis in vivo, that is CD31+ vessel density was increased after the transfer of MSC compared with siVEGF-MSC, and a supportive role inAngiogenesis is suggested.